MedPath

effectiveness of tranexemic acid in reducing blood loss in vaginal hystrectomy

Phase 2
Conditions
Health Condition 1: N996- Intraoperative hemorrhage and hematoma of a genitourinary system organ or structure complicating a procedureHealth Condition 2: N996- Intraoperative hemorrhage and hematoma of a genitourinary system organ or structure complicating a procedureHealth Condition 3: O- Medical and Surgical
Registration Number
CTRI/2023/03/050830
Lead Sponsor
Dr Meenakshi Gothwal
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All females scheduled for benign vaginal hystrectomy

Exclusion Criteria

Allergic to tranexemic acid, history of seizures,history of venous or arterial thromboembolism or active thromboembolic disease, severe renal impairment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath